Metabolic Reprogramming in Diabetes

Metabolic reprogramming in diabetes refers to the shift in cellular metabolism that occurs in response to insulin resistance and altered glucose handling. In Type 2 Diabetes, cells begin to rely more on fatty acids and less on glucose for energy, a process that disrupts normal metabolic functions and contributes to insulin resistance. This shift is linked to changes in mitochondrial function, nutrient sensing pathways, and cellular signaling. Researchers are investigating ways to reverse this reprogramming by targeting key metabolic pathways to restore normal glucose metabolism and improve insulin sensitivity. Approaches like dietary interventions, exercise, and pharmacological agents aim to restore metabolic balance, offering potential new treatments for diabetes and related complications.

    Related Conference of Metabolic Reprogramming in Diabetes

    February 09-10, 2026

    20th International Conference on Endocrinology, Diabetes and Metabolism

    Singapore City, Singapore
    February 12-13, 2026

    5th Global Summit on Physiology and Metabolism of Thyroid

    Singapore City, Singapore
    February 23-24, 2026

    19th International Summit on Diabetes

    London, UK
    February 25-26, 2026

    16th World Congress on Endocrinology and Diabetes

    Paris, France
    March 26-27, 2026

    7th Global summit on Diabetes and Endocrinology

    Amsterdam, Netherlands
    May 14-15, 2026

    7th World Summit on Diabetes

    Rome, Italy
    May 18-19, 2026

    57th Annual Congress on Endocrinology and Diabetes Research

    Aix-en-Provence, France
    August 17-18, 2026

    4th World congress and Expo on Diabetes

    Toronto, Canada

    Metabolic Reprogramming in Diabetes Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in